Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells

International Journal of Molecular Medicine ◽

10.3892/ijmm.19.2.301 ◽

2007 ◽

Author(s):

Tami Ueda ◽

Noriyuki Takai ◽

Masakazu Nishida ◽

Kaei Nasu ◽

Hisashi Narahara

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Ovarian Cancer Cells ◽

Deacetylase Inhibitor ◽

Growth Activity

Download Full-text

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus

10.18632/oncotarget.25242 ◽

2018 ◽

Vol 9 (41) ◽

pp. 26328-26341 ◽

Author(s):

Sarah L. Hulin-Curtis ◽

James A. Davies ◽

Rachel Jones ◽

Emma Hudson ◽

Louise Hanna ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Trichostatin A ◽

Oncolytic Adenovirus ◽

Ovarian Cancer Cells ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

Abstract 4730: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP-ribose polymerase inhibitor olaparib

10.1158/1538-7445.am2016-4730 ◽

2016 ◽

Author(s):

Kofi Sarfo-Kantanka ◽

Andrew J. Wilson ◽

Alexandra Steck ◽

Jeanette Saskowski ◽

Dineo Khabele

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Cyclin E ◽

Ovarian Cancer Cells ◽

Deacetylase Inhibitor ◽

Polymerase Inhibitor

Download Full-text

A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells

International Journal of Molecular Medicine ◽

10.3892/ijmm.17.2.323 ◽

2006 ◽

Author(s):

Noriyuki Takai ◽

Tami Ueda ◽

Masakazu Nishida ◽

Kaei Nasu ◽

Hisashi Narahara

Keyword(s):

Ovarian Cancer ◽

Endometrial Cancer ◽

Growth Inhibition ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Ovarian Cancer Cells ◽

Cycle Arrest ◽

Deacetylase Inhibitor

Download Full-text

Abstract B37: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP ribose polymerase inhibitors via E2F1 downregulation.

10.1158/1538-7445.chromepi15-b37 ◽

2016 ◽

Author(s):

Andrew J. Wilson ◽

Jeanette Saskowski ◽

Dineo Khabele

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Cyclin E ◽

Ovarian Cancer Cells ◽

Polymerase Inhibitors ◽

Deacetylase Inhibitor

Download Full-text

Abstract B81: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to the cyclin-dependent kinase 2 inhibitor dinaciclib.

10.1158/1557-3265.ovca15-b81 ◽

2016 ◽

Author(s):

Andrew J. Wilson ◽

Jeanette Saskowski ◽

Dineo Khabele

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Cyclin E ◽

Ovarian Cancer Cells ◽

Cyclin Dependent Kinase ◽

Deacetylase Inhibitor

Download Full-text

Abstract A15: The histone deacetylase inhibitor panobinostat sensitizes cyclin E-amplified ovarian cancer cells to poly ADP ribose polymerase inhibitors via E2F1 downregulation.

10.1158/1557-3265.ovca15-a15 ◽

2016 ◽

Author(s):

Andrew J. Wilson ◽

Jeanette Saskowski ◽

Dineo Khabele

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Cyclin E ◽

Ovarian Cancer Cells ◽

Polymerase Inhibitors ◽

Deacetylase Inhibitor

Download Full-text

The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells

Anticancer Research ◽

10.21873/anticanres.11156 ◽

2016 ◽

Vol 36 (11) ◽

pp. 5731-5742 ◽

Author(s):

KAROLINA LAPINSKA ◽

GENEVIEVE HOUSMAN ◽

SHANNON BYLER ◽

SARAH HEERBOTH ◽

AMBER WILLBANKS ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Ovarian Cancer Cells ◽

Calpain Inhibitor ◽

Combination Therapies ◽

Deacetylase Inhibitor ◽

Inhibitor Combination

Download Full-text

A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells

Cancer Biology & Therapy ◽

10.4161/cbt.20086 ◽

2012 ◽

Vol 13 (8) ◽

pp. 681-693 ◽

Author(s):

Curt Balch ◽

Kaleb Naegeli ◽

Seungyoon Nam ◽

Brett Ballard ◽

Alan Hyslop ◽

...

Keyword(s):

Ovarian Cancer ◽

Signal Transduction ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Microrna Expression ◽

Ovarian Cancer Cells ◽

Deacetylase Inhibitor ◽

Chemoresistant Ovarian Cancer

Download Full-text

Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells

International Journal of Oncology ◽

10.3892/ijo_00000690 ◽

2010 ◽

Vol 37 (2) ◽

Author(s):

Kim

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hydroxamic Acid ◽

Ovarian Cancer Cells ◽

Human Ovarian Cancer ◽

Anticancer Effects ◽

Deacetylase Inhibitor

Download Full-text

Retraction notice to “M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells” [Gynecol. Oncol. 101 (2006) 108–113]

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.09.022 ◽

2013 ◽

Vol 129 (1) ◽

pp. 270

Author(s):

Noriyuki Takai ◽

Tami Ueda ◽

Masakazu Nishida ◽

Kaei Nasu ◽

Hisashi Narahara

Keyword(s):

Ovarian Cancer ◽

Endometrial Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Ovarian Cancer Cells ◽

Cycle Arrest ◽

Deacetylase Inhibitor ◽

Retraction Notice

Download Full-text